• Pediatric Cardiology

• Chief of Staff of Holtz Children's Hospital
• Executive Associate Dean for Child Health
• Professor and Chairman of Pediatrics

Pediatric Cardiology

To prevent cardiomyopathy and heart failure in children and young adults.

The development of surrogate outcome measures and biomarkers of adult-onset disease, such as coronary artery disease and heart failure, helps to identify prenatal and postnatal factors that moderate their natural history.

Translating research advances to clinical care through clinical trials.

Researching the efficacy, long-term side effects, and outcomes of pharmacological agents in children by use of cross-sectional and longitudinal approaches.

Steven E. Lipshultz, M.D. was appointed Chairman of the Department of Pediatrics in August 2003. Dr. Lipshultz received his Doctor of Medicine from Dartmouth Medical School. He then went to Case Western Reserve University School of Medicine for his residency in pediatrics, followed by his fellowships in clinical cardiology and research at Children's Hospital in Boston. Dr. Lipshultz most recently served as Associate Chairman of Pediatrics for Strategic Planning and Chief of Pediatric Cardiology at the University of Rochester Medical Center at Golisano Children's Hospital at Strong. Dr. Lipshultz has served on the faculties at Harvard Medical School and Boston University School of Medicine. He has been the principal investigator in a number of groundbreaking NIH studies on the causes and treatment of cardiomyopathies in children. His clinical trials have discovered therapies that can prevent heart disease in children with HIV. Another major focus of his research has been the long term heart damage that can be caused by treatments for cancer, such as chemotherapy or radiation therapy.